微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 77.55% | -4.47% | -0.23% | 23/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 77.73% | -5.27% | -2.63% | 23/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 79.82% | -2.52% | -0.24% | 19/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 80.01% | -3.89% | -1.44% | 25/160 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 81.18% | -3.75% | -1.06% | 22/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 82.05% | -2.67% | 0.2% | 20/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 81.89% | -1.35% | -1.64% | 20/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 83.25% | -3.18% | -1.29% | 17/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 84.34% | -3.26% | 0.05% | 14/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 84.3% | -4.23% | 1.56% | 16/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 83.01% | -6.2% | -3.47% | 17/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 85.99% | -2.96% | -1.37% | 16/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 87.19% | -1.99% | -0.95% | 12/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 88.02% | -0.86% | -0.54% | 12/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 88.5% | 2% | -0.13% | 8/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 88.61% | -1.82% | -0.38% | 11/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 88.95% | 70.99% | 0.19% | 8/160 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 88.78% | 25.9% | -1.63% | 7/160 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
| 2019-12-31 | 90.25% | 1.82% | 1.82% | 5/160 | -1204.25% | 多瑞医药 | 95.59% | 行业排名> |
| 2018-12-31 | 88.64% | 4.22% | 4.22% | 7/160 | -205.91% | 微芯生物 | 95.81% | 行业排名> |
| 2017-12-31 | 85.04% | 7.3% | 7.3% | 11/160 | 52.58% | 微芯生物 | 96.09% | 行业排名> |
| 2016-12-31 | 79.26% | 43.33% | 12.4% | 10/160 | 48.44% | 微芯生物 | 96.11% | 行业排名> |
| 2016-06-30 | 70.52% | 2% | 27.52% | 15/160 | 46.2% | 微芯生物 | 95.5% | 行业排名> |
| 2015-12-31 | 55.3% | 9.62% | 6.3% | 33/160 | 46.24% | 微芯生物 | 96.27% | 行业排名> |
| 2015-09-30 | 52.02% | 2% | 3.13% | 27/160 | 44.69% | 贝达药业 | 95.47% | 行业排名> |